Get the Stockscreener App
2.52
3.45%
-0.09
Pre-market:
2.52
Clover Health Investments Corp stock is traded at $2.52, with a volume of 8.38M.
It is down -3.45% in the last 24 hours and down -14.29% over the past month.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
See More
Previous Close:
$2.61
Open:
$2.62
24h Volume:
8.38M
Relative Volume:
0.95
Market Cap:
$1.06B
Revenue:
$1.70B
Net Income/Loss:
$-123.70M
P/E Ratio:
-9.463
EPS:
-0.2663
Net Cash Flow:
$-178.21M
1W Performance:
+0.80%
1M Performance:
-14.29%
6M Performance:
-44.62%
1Y Performance:
-20.75%
1-Day Range:
$2.47
$2.63
1-Week Range:
$2.47
$2.725
52-Week Range:
$2.12
$4.87
Clover Health Investments Corp Stock (CLOV) Company Profile
Name
Clover Health Investments Corp
Sector
Industry
Phone
(201) 432-2133
Address
30 MONTGOMERY STREET, JERSEY CITY
Compare CLOV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLOV
Clover Health Investments Corp
|
2.52 | 1.36B | 1.70B | -123.70M | -178.21M | -0.2663 |
|
UNH
Unitedhealth Group Inc
|
304.24 | 275.33B | 422.82B | 22.09B | 25.27B | 23.08 |
|
CVS
Cvs Health Corp
|
70.97 | 87.01B | 386.46B | 4.49B | 4.78B | 3.58 |
|
CI
Cigna Group
|
302.11 | 79.24B | 261.22B | 5.40B | 3.94B | 18.32 |
|
ELV
Elevance Health Inc
|
312.00 | 69.71B | 189.25B | 5.35B | 5.34B | 23.50 |
|
HUM
Humana Inc
|
288.25 | 34.44B | 123.11B | 1.58B | 2.44B | 13.03 |
Clover Health Investments Corp Stock (CLOV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-17-24 | Initiated | Craig Hallum | Buy |
| Oct-07-24 | Initiated | UBS | Neutral |
| Feb-02-22 | Initiated | Canaccord Genuity | Buy |
| Feb-02-22 | Upgrade | Cowen | Underperform → Market Perform |
| Jan-19-22 | Initiated | SVB Leerink | Mkt Perform |
| Jan-10-22 | Resumed | Citigroup | Neutral |
| Jan-07-22 | Downgrade | Credit Suisse | Neutral → Underperform |
| Sep-10-21 | Initiated | Cowen | Underperform |
| Sep-02-21 | Resumed | Citigroup | Neutral |
| Jul-12-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Jun-10-21 | Downgrade | BofA Securities | Neutral → Underperform |
| May-17-21 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-09-21 | Initiated | Credit Suisse | Neutral |
| Feb-02-21 | Initiated | Citigroup | Buy |
| Feb-01-21 | Initiated | JP Morgan | Neutral |
View All
Clover Health Investments Corp Stock (CLOV) Latest News
Clover Health Investments, Corp. Rings the Nasdaq Stock Market Closing Bell - Nasdaq
Clover Health Investments, Corp. Rings the Closing Bell - Nasdaq
Will Clover Health Investments Corp. benefit from macro trendsBull Run & Verified Trade Idea Suggestions - Newser
Why Clover Health Investments Corp. stock attracts strong analyst attention2025 Key Highlights & Daily Stock Trend Watchlist - theviewers.co.kr
'SPAC King' Chamath Palihapitiya Returns With $250 Million 'American Exceptionalism' Deal Targeting AI, Energy, DefenseClover Health Investments (NASDAQ:CLOV), Opendoor Technologies (NASDAQ:OPEN) - Benzinga
Support Zone Holds Steady for Clover Health Investments Corp. After DipStop Loss & Comprehensive Market Scan Insights - sundaytimes.kr
Drawdown in Clover Health Investments Corp. May Be Nearing End2025 Trading Recap & Free Weekly Chart Analysis and Trade Guides - newsimpact.co.kr
Ichimoku Cloud Indicates Uncertainty Around Clover Health Investments Corp.2025 Institutional Moves & Safe Entry Trade Reports - sundaytimes.kr
Canaccord Lowers Clover Health (CLOV) PT to $4.10 Despite Strong Q2 Growth - Yahoo Finance
Clover Health (CLOV) Achieves Profitability as Medicare Advantage Membership Surges - Insider Monkey
13 Most Promising Penny Stocks Under $5 - Insider Monkey
Is now the right time to enter Clover Health Investments Corp.July 2025 Analyst Calls & Daily Entry Point Trade Alerts - thegnnews.com
Clover Health Reports Second Quarter 2025 Results; Delivering Strong Sustainable Growth - ADVFN Brasil
Clover drops despite Q2 beat amid concerns over medical cost trends - MSN
Is Clover Health (CLOV) Reassessing Its Path to Profitability After Latest Shift to Net Loss? - simplywall.st
Clover Health Investments Director Loengard Anna U Buys 12000 Shares at $2.6/Share - AInvest
Loengard Anna U buys Clover Health investments (CLOV) shares By Investing.com - Investing.com Canada
Can Clover Health Investments Corp. Overcome Bearish SentimentJuly 2025 Macro Moves & AI Enhanced Market Trend Forecasts - metal.it
Clover Health, Surgery Partners, Illumina, Bruker, and Supernus Pharmaceuticals Shares Skyrocket, What You Need To Know - ca.finance.yahoo.com
Clover Health rises after former CEO buys shares - MSN
Clover Health Addresses Shareholder Concerns with FAQ Release - AInvest
Healthcare AI Market Explodes 38.5% Annually as Diagnostics Gain FDA Traction - The Globe and Mail
Clover Health at Canaccord Conference: Strategic Tech-Driven Growth - Investing.com
Clover Health Investments : August 2025 Investor Presentation - MarketScreener
Clover Health Engages Shareholders with FAQ Release - TipRanks
Clover Health Set To Join Russell 3000® Index - Barchart.com
Insider Buying at Clover Health: A Signal of Value or Short-Term Confidence? - AInvest
Clover Health rises after former CEO buys shares (CLOV) - Seeking Alpha
Clover Health: Short-Term Pain Hides Its Long-Term Profitability Potential (NASDAQ:CLOV) - Seeking Alpha
Clover Health Stock (CLOV): Insider Confidence Sparks Rally - Value The Markets
Co-Founder & Executive Chairman of Clover Health Investments Vivek Garipalli Buys 32% More Shares - simplywall.st
Clover Health Investments Maintains Hold Rating from Leerink Partners, Price Target at $2.50 - AInvest
Clover Health 2025 Q2 Earnings Net Loss Widens by 242.8% - AInvest
CLOVER HEALTH INVESTMENTS, CORP. /DE SEC 10-Q Report - TradingView
Clover Health Earnings Call: Growth and Profitability Insights - The Globe and Mail
Clover Health Investments, Corp. (NASDAQ:CLOV) Q2 2025 Earnings Call Transcript - Insider Monkey
Clover Health Investments Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Clover Health shares rise 1.33% premarket after 2Q25 earnings call and UBS price target adjustment. - AInvest
Clover Health CEO Reynoso sells $19,718 in shares By Investing.com - Investing.com Canada
Clover Health CEO Reynoso sells $19,718 in shares - Investing.com India
Clover Health Reports Strong Q2 2025 Growth - The Globe and Mail
Clover Health Investments, Corp. (CLOV) Q2 Earnings Meet Estimates - MSN
Clover Health stock drops on Q2 report release - Nashville Post
Clover stock drops despite Q2 beat (CLOV:NASDAQ) - Seeking Alpha
Clover Health Posts Rising Revenue And Beats Profit Targets - Finimize
Clover Health Investments Corp Stock (CLOV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Clover Health Investments Corp Stock (CLOV) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Garipalli Vivek | Director |
Aug 07 '25 |
Buy |
2.24 |
415,000 |
929,600 |
1,824,267 |
| Garipalli Vivek | Director |
Aug 08 '25 |
Buy |
2.17 |
31,980 |
69,397 |
1,856,247 |
| Reynoso Jamie L. | CEO, Medicare Advantage |
Aug 04 '25 |
Sale |
2.89 |
6,823 |
19,718 |
3,261,485 |
4.37%
2.78%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):